07.05.2021 • NewsAzelis

Azelis Boosts US Life Sciences with Vigon Buy

Azelis has entered into an agreement to buy US-based Vigon International, expanding its footprint in the life sciences sector. Financial details of the transaction expected to close in the second quarter of 2021 were not disclosed.

Based in East Stroudsburg, Pennsylvania, Vigon is a specialty distributor and manufacturer of ingredients for the flavors, fragrances and cosmetics markets. Its portfolio includes flavors, natural and synthetic aroma chemicals, actives, functional ingredients and essential oils. The company has 120 employees and serves more than 1,000 customers across the three market segments.

“As a leader in the US flavors and fragrances market segments, Vigon provides Azelis the impetus for geographic expansion in these markets across North America, as well as a platform for future acquisitions of complementary businesses in the food ingredients segments,” said Azelis Americas CEO and president Frank Bergonzi. “Vigon’s co-manufacturing and blending capabilities provide us an added value proposition that we can leverage to better serve our principals and customers.”

Azelis Americas is headquartered in Westport, Connecticut and serves suppliers and customers in the US, Canada and Mexico. The business was formerly known as Koda Distribution Group until it was acquired by Azelis in December 2015.

Author: Elaine Burridge, Freelance Journalist

Azelis is buying US-based Vigon International, expanding its footprint in the...
Azelis is buying US-based Vigon International, expanding its footprint in the life sciences sector. Based in East Stroudsburg, Pennsylvania, Vigon is a specialty distributor and manufacturer of ingredients for flavors, fragrances and cosmetics. The deal should close in Q2 2021. (c) Azelis

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.